Evidence map›Paper›PMID 38534207›Full record

ArticleAntibodies (Basel, Switzerland)2024

Platform-Specific Fc

Ellena Nador, Chaoshuang Xia, Philip J Santangelo, Kevin J Whaley, Catherine E Costello, Deborah J Anderson

Open access · goldAbstract read
In one paragraph

Article in Antibodies (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ellena NadorDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.ORCID 0000-0001-8288-0846
Chaoshuang XiaCenter for Biomedical Mass Spectrometry, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.ORCID 0000-0001-7076-4813
Philip J SantangeloWallace H. Coulter Department of Biomedical Engineering, Emory University, Atlanta, GA 30322, USA.
Kevin J WhaleyZabBio, Inc., San Diego, CA 92121, USA.ORCID 0000-0003-3856-6803
Catherine E CostelloCenter for Biomedical Mass Spectrometry, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.ORCID 0000-0003-1594-5122
Deborah J AndersonDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.
Boston University · USThe Wallace H. Coulter Department of Biomedical Engineering · US

Funding

Project 3: Film Formulation, PK/PD and Safety Studies of ZB-06P50HD096957 · NICHD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ANDERSON, DEBORAH J, WHALEY, KEVIN · 2019 to 2025
$12.9M
Legacy Support During Closure of the Mass Spectrometry Resource for Biology and MedicineR24GM134210 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI COSTELLO, CATHERINE E. · 2019 to 2021
$2.1M
Synthetic mRNA-mediated reversible immunocontraceptionR33HD099745 · NICHD · EMORY UNIVERSITY · PI ANDERSON, DEBORAH J, SANTANGELO, PHILIP J · 2021 to 2023
$2.0M
A Thermo-Fisher Scientific Orbitrap Fusion Lumos Tribrid Mass Spectrometer SystemS10OD021728 · OD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI COSTELLO, CATHERINE E. · 2018 to 2018
$1.4M
NICHD NIH HHS P50 HD096957NICHD NIH HHS R33 HD099745NIGMS NIH HHS R24 GM134210NIH HHS P50 HD096957NIH HHS R24 GM134210NIH HHS R33 HD099745NIH HHS S10 OD021728
6 · The paper itself

Abstract

IgG Fc

Indexed as

contraceptionFc receptormanufacturingmass spectrometrymonoclonal antibodiesmRNAN-glycosylation

Identifiers

PMID38534207
PMCPMC10967333
OpenAlexW4392518164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.